Anonymous
Guest
Anonymous
Guest
"Still, analysts noted that Amgen seems to have gotten a bargain for an asset that shows immense promise by buying Onyx for $125 a share. That amounts to $5 a share more than what the company originally offered in July".
http://blogs.marketwatch.com/health...-bigger-gains-than-seller-in-amgen-onyx-deal/
Thanks again TC!
http://blogs.marketwatch.com/health...-bigger-gains-than-seller-in-amgen-onyx-deal/
Thanks again TC!